Gainers Axcella Health Inc. (NASDAQ: AXLA) shares climbed 196% to $0.3335 after the company announced it was granted a patent for long COVID fatigue treatment.
NeuBase Therapeutics, Inc. (NASDAQ:NBSE – Free Report) – Equities researchers at Chardan Capital increased their FY2023 earnings per share estimates for shares of NeuBase Therapeutics in a research note issued to investors on Wednesday, August 16th. Chardan Capital analyst K. Nakae now forecasts that the company will post earnings per share of ($5.19) for the […]
Aug. 8—A South Oakland gene therapy company that suspended development work last week to consider operational alternatives is licensing its technology to a new startup that aims to treat an
NeuBase Therapeutics, Inc. (NASDAQ:NBSE – Get Free Report) was the target of a large growth in short interest in the month of June. As of June 30th, there was short interest totalling 71,500 shares, a growth of 108.5% from the June 15th total of 34,300 shares. Based on an average trading volume of 72,200 shares, […]
NeuBase Therapeutics, Inc. (NASDAQ:NBSE – Free Report) saw a large drop in short interest in the month of June. As of June 15th, there was short interest totalling 34,300 shares, a drop of 93.8% from the May 31st total of 554,800 shares. Based on an average trading volume of 62,600 shares, the short-interest ratio is […]